This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Aug;60(2):223-5; discussion 228-30.

doi: 10.1016/j.eururo.2011.04.006. Epub 2011 Apr 16.

Prostate cancer biomarkers to improve risk stratification: is our knowledge of prostate cancer sufficient to spare prostate biopsies safely?

Monique J Roobol

PMID: 21514038
DOI: 10.1016/j.eururo.2011.04.006

Editorial

Prostate cancer biomarkers to improve risk stratification: is our knowledge of prostate cancer sufficient to spare prostate biopsies safely?

Monique J Roobol. Eur Urol. 2011 Aug.

. 2011 Aug;60(2):223-5; discussion 228-30.

doi: 10.1016/j.eururo.2011.04.006. Epub 2011 Apr 16.

Author

Monique J Roobol

PMID: 21514038
DOI: 10.1016/j.eururo.2011.04.006

No abstract available

PubMed Disclaimer

Comment on

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P. Guazzoni G, et al. Eur Urol. 2011 Aug;60(2):214-22. doi: 10.1016/j.eururo.2011.03.052. Epub 2011 Apr 5. Eur Urol. 2011. PMID: 21482022

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information